Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)

Clinical trial NCT05259319 · UNKNOWN

Trial details

NCT number: NCT05259319
Sponsor: Centre Georges Francois Leclerc
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Non Small Cell Lung Cancer Metastatic Bladder Cancer Metastatic Renal Cell Carcinoma Metastatic Head and Neck Cancer

Start date: 2022-12-05
Primary completion: 2024-12-05
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.